Ownership stake · Activity not yet classified
Insight Pharmaceuticals
Transaction overview
Reported completed
Announced:
Exact closing date not established.
Swander Pace reported finalizing its sale of Insight Pharmaceuticals to Prestige Brands Holdings.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- Swander Pace Capital Finalizes Sale of Insight Pharmaceuticals for $750 Million ↗
Swander Pace Capital · Published Sep 3, 2014
Reports a finalized sale and includes a same-day sale reference. The proposal conservatively leaves the exact legal closing-date field unset.